Diopsys Inc. Agrees to $14.25 Million Settlement Over False Claims
Diopsys Inc., a medical device company based in Pennsylvania, is reaching into its coffers to settle a significant legal matter, agreeing to pay up to $14.25 million to resolve allegations of submitting false claims to Medicare and Medicaid. The claims were tied to the company’s NOVA device, a piece of equipment cleared by the FDA for visual evoked potential (VEP) testing. But it turns out, the device was being used in ways it wasn’t approved for—something the government says led to false claims for payment from both Medicare and Medicaid.